Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Terzuoli, Erika ^a   Meini, Stefania ^b   Cucchi, Paola ^b   Catalani, Claudio ^b   Cialdai, Cecilia ^b   Maggi, Carlo Alberto ^b   Giachetti, Antonio ^a   Ziche, Marina ^a   Donnini, Sandra ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BRADYKININ; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; ORNITHINE; OSTEOARTHRITIS; RATS; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; SULFONAMIDES; TIGHT JUNCTIONS;

EID: 84894258381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084358     Document Type: Article

References (38)

1. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, et al (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3: 1208.
2. Shaw OM, Harper JL (2011) Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis. Biochem Biophys Res Commun 416: 266-9.
3. Wieczorek M, Pilyawskaya A, Burkard M, Zuzack JS, Jones SW, et al (1997). Bradykinin Antagonists in human systems: correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum. Biochemical Pharmacology 54: 283-291. (Pubitemid 27357005)
4. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, et al (1998) B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol 124: 1286-1292. (Pubitemid 28333954)
5. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M (2001) The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 15: 1487-98.
6. Cao T, Brain SD, Khodr B, Khalil Z (2002) B1 and B2 antagonists and bradykinin-induced blood flow in rat skin inflammation. Inflamm Res 51: 295-9. (Pubitemid 34628032)
7. Bas M (2012) Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial. Expert Rev Clin Immunol 8: 707-17.
8. Bond AP, Lemon M, Dieppe PA, Bhoola KD (1997) Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacol 36: 209-216. (Pubitemid 27286323)
9. Meini S, Maggi CA (2008) Knee osteoarthritis: a role for bradykinin? Inflamm Res 57: 351-61.
10. Bellucci F, Cucchi P, Catalani C, Giuliani S, Meini S, et al (2009) Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts. Br J Pharmacol 158: 1996-2004.
11. Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, et al (2011a) Bradykinin and B(2) receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol 162: 611-622.
12. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57: 27-77. (Pubitemid 40283969)
13. Fincham CI, Bressan A, Paris M, Rossi C, Fattori D (2009) Bradykinin receptor antagonists-a review of the patent literature 2005-2008. Expert Opin Ther Pat 19: 919-41.
14. Charignon D, Späth P, Martin L, Drouet C (2012) Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems. Expert Opin Pharmacother 13: 2233-47.
15. Cucchi P, Meini S, Bressan A, Catalani C, Bellucci F, et al (2005) MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology andmolecular characterization. Eur J Pharmacol 528:7-16. (Pubitemid 41773646)
16. Meini S, Cucchi P, Bellucci F, Catalani C, Giuliani S, et al (2007) Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies. Br J Pharmacol 150: 313-20. (Pubitemid 46221040)
17. Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, P etal (2009) Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays. Eur J Pharmacol 615: 10-6.
18. Meini S, Cucchi P, Catalani C, Bellucci F, Santicioli P, et al (2010) Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle. Eur J Pharmacol 635: 34-9.
19. Valenti C, Cialdai C, Giuliani S, Tramontana M, Quartara L, et al (2008) MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways. Eur J Pharmacol 579: 350-6.
20. Valenti C, Giuliani S, Cialdai C, Tramontana M, Maggi CA (2010) Anti-inflammatory synergy of MEN16132, a kinin B2 receptor antagonist, and dexamethasone in carrageenan-induced knee joint arthritis in rats. Br J Pharmacol 161: 1616-27.
21. Cialdai C, Giuliani S, Valenti C, Tramontana M, Maggi CA (2009) Effect of Intra-articular4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8- quinolyloxymethyl) phenylsulfo namido]-tetrahydro-2H-4-pyranylcarbonyl] piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. J Pharmacol Exp Ther 331: 1025-32.
22. Gomis A, Meini S, Miralles A, Valenti C, Giuliani S, et al, (2013) Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant. Osteoarthritis Cartilage 21: 1346-1354.
23. Walsh DA, Haywood L (2001) Angiogenesis: a therapeutic target in arthritis. Curr Opin Investig Drugs 2: 1054-63. (Pubitemid 32780704)
24. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, et al (2003) Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48: 2173-7. (Pubitemid 36959197)
25. Walsh DA, Bonnet CS, Turner EL, Wilson D, Situ M, et al (2007) Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 15: 743-51. (Pubitemid 46893968)
26. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-57.
27. Spinetti G, Fortunato O, Cordella D, Portararo P, Kränkel N, et al (2011) Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ Res 108: 284-93.
28. Frimm Cde, Sun Y, Weber KT (1996) Wound healing following myocardial infarction in the rat: role for bradykinin and prostaglandins. J. Mol. Cell Cardiol. 28: 1279-1285.
29. Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504. (Pubitemid 41613541)
30. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10: 923-34.
31. Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7: 803-15. (Pubitemid 47480307)
32. Finetti F, Donnini S, Giachetti A, Morbidelli L, Ziche M (2009) Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circ Res 105: 657-66.
33. Meini S, Bellucci F, Catalani C, Cucchi P, Giolitti A, et al (2011b) Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor. Br J Pharmacol 162: 1202-1212.
34. Barnes PJ, Karin M (1997) Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071. (Pubitemid 27163860)
35. Tak PP, Firestein GS (2001) NF-kappa B: a key role in inflammatory diseases. J Clin Invest 107: 7-11. (Pubitemid 32047405)
36. Tirziu D, Jaba IM, Yu P, Larrivée B, Coon BG, et al (2012) Endothelial nuclear factor-kB-dependent regulation of arteriogenesis and branching. Circulation 126: 2589-600.
37. Wohlfart P, Dedio J, Wirth K, Schölkens BA, Wiemer G (1997) Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. J Pharmacol Exp Ther 280: 1109-16. (Pubitemid 27171379)
38. Donnini S, Solito R, Cetti E, Corti F, Giachetti A, et al (2010) Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. FASEB J 24: 2385-95.